Tag

License Agreement

All articles tagged with #license agreement

business2 years ago

FTC Challenge Forces Sanofi to Terminate $750M Maze Therapeutics Deal

Sanofi expresses disappointment with the Federal Trade Commission's decision to seek a preliminary injunction against its proposed licensing agreement with Maze Therapeutics for the development of MZE001, a potential treatment for Pompe Disease. Sanofi disagrees with the action, stating that it would delay potential advancements and impact patients' lives. As a result, Sanofi has decided to terminate the agreement with Maze Therapeutics. The company remains committed to addressing the unmet needs of the Pompe patient community.

technology2 years ago

Meta's Llama 2: The Non-Open Source AI Competitor to ChatGPT

Meta's newly released large language model, Llama 2, is being criticized for not truly being open source. The Llama 2 Community License Agreement includes restrictions on training other language models and requires a special license for apps or services with over 700 million monthly users. Open-source advocates argue that these limitations contradict the principles of open source, which should allow developers and users to freely use and modify the technology without seeking permission. The license's language and the lack of a public drafting or comment process have raised concerns among experts, who argue that the license is not truly open source.

healthcare2 years ago

"NANOBIOTIX Partners for Global Development and Commercialization of Groundbreaking Radioenhancer NBTXR3"

Nanobiotix has announced a global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica for the investigational radioenhancer NBTXR3, which is being evaluated in several studies for the treatment of solid tumors. Under the agreement, Nanobiotix will grant Janssen a worldwide license for the development and commercialization of NBTXR3, with Nanobiotix receiving near-term cash and operational support valued up to $60 million. Nanobiotix will maintain operational control of ongoing studies and NBTXR3 manufacture, while Janssen will be responsible for an initial Phase 2 study for lung cancer. Nanobiotix is eligible for success-based payments of up to $1.8 billion, as well as royalties on net sales of NBTXR3.

gaming2 years ago

Escape from Tarkov Devs Warn Against Sharing Illegally Obtained Info

Battlestate Games, the developer of Escape from Tarkov, has announced that it will ban players who datamine "information that is intentionally hidden from users" and any players who share it. The studio defined datamining as "illegal infiltration of in-game code and databases" and said that "in-game accounts involved in datamining and/or sharing data originating from datamining" will be banned, with "further actions taken afterwards". The company believes that datamining is a direct breach of the license agreement and that it is not fair on the development team to have its work "revealed by a dataminer".